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Influence of Left Ventricular Geometric Patterns on Prognosis in
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Objectives. We sought to examine patterns of left ventricular
(LV) geometry as determined by echocardiography and their
association with mortality in patients with or without coronary
artery disease (CAD).
Background. The independent prognostic role of LV geometry
remains uncertain.
Methods. We performed a cohort study based on 988 consecu-
tive patients who underwent both coronary arteriography for
presumed CAD and echocardiography and were followed up for a
mean of 9 years (range 5 to 13). Patients were classified into four
LV geometry patterns: normal, concentric remodeling, eccentric
LV hypertrophy (LVH) and concentric LVH.
Results. Patients with concentric LVH consistently showed the
largest increase in LV posterior wall and septal thickness and LV
mass index, as well as relative wall thickness (RWT), regardless of
status of the coronary arteries. This pattern conferred the highest
risk of both all-cause and cardiac mortality. Eccentric LVH
moderately increased the risk of death compared with normal
geometry; no substantial increase in mortality was noted in
patients with concentric remodeling. When LV index and RWT
were analyzed as continuous measures and considered in the same
Cox proportional hazards model, increases in LV mass were
independently associated with risk, but this outcome was less
clear for RWT.
Conclusions. In this series of patients referred to coronary
angiography for suspected CAD, LVH conferred most of the
predictive information from echocardiography. Patients with both
LVH and abnormal RWT—concentric LVH—represent a group
with the greatest mortality risk. Concentric remodeling may not
be associated with increased risk of death because the predictive
value of RWT is not as strong as for LV mass.
(J Am Coll Cardiol 1998;31:1635–40)
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The prognostic role of echocardiographically determined left
ventricular hypertrophy (LVH) has been well established
(1–7). Recently, the pattern of left ventricular (LV) adaptation
to hypertension as determined by measurement of relative wall
thickness (RWT) has been characterized, and different hemo-
dynamic patterns have been described (8–14). It has been
proposed that the geometry of the left ventricle carries prog-
nostic information beyond that provided by LV mass (6).
However, in part because it poses difficult analytic challenges,
the prognostic role of LV geometry is still unresolved (15–17).
To further characterize the various geometric patterns of the
left ventricle and, more importantly, to determine the influ-
ence of those various patterns on prognosis, we analyzed a
prospective cohort of 988 predominantly African American
and hypertensive patients.
Methods
Study patients. The patients were recruited from Cook
County Hospital, a 650-bed public general hospital in Chicago,
Illinois. Between June 1982 and December 1990, 2,971 con-
secutive patients who had undergone cardiac catheterization as
part of a diagnostic evaluation for presumed coronary artery
disease (CAD) were enrolled. Medical history was collected by
personal interview or from medical records, using a standard-
ized questionnaire. Patients with valvular disease were ex-
cluded. Echocardiographic data were available for 1,317 pa-
tients. Patients with impaired systolic function, defined by a LV
ejection fraction ,45% (n 5 299) were excluded to eliminate
the confounding effect of impaired contractility of the left
ventricle on LV mass and prognosis. We also excluded patients
with hypertrophic cardiomyopathy, defined by a ratio of septal
to posterior wall thickness $1.5 with posterior wall thickness
$1.2 cm (n 5 10) and patients for whom data on body surface
area were unavailable (n 5 20). Thus, our final sample
included 988 patients.
Echocardiography. Patients were studied using two-
dimensionally guided M-mode echocardiography in standard
views. Measurements were made according to the recommen-
dations of the American Society of Echocardiography (ASE)
using a leading edge to leading edge convention (18). LV
internal dimension, septal thickness and LV posterior wall
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thickness were measured at end diastole as defined by the
onset of the QRS complex. RWT was calculated as follows: 2 3
LV posterior wall thickness/LV end diastolic dimension 3
100%. A value of $45% was defined as abnormal. LV mass
was calculated using the formula (19): ASE 2 cube LV mass 5
1.05 ([LV internal diameter 1 LV septal thickness 1 posterior
wall thickness]3 2 [LV internal diameter]3). Because this
calculation results in an overestimation of LV mass by about
20%, the formula developed by Devereux et al. (20) was used
to recalculate the corrected LV mass, which was similar to that
derived using the Penn convention measurement: 0.80 (ASE 2
cube LV mass) 1 0.6. The LV index was calculated by dividing
LV mass by body surface area to adjust for body size. The
cutoffs of 131 g/m2 for men and 100 g/m2 for women developed
in the Framingham Heart Study (21) were used to define the
presence of LVH. Alternative analyses using LV mass indexed
for height (21) and to height2.7 (22) were also done to define
LVH.
The patients were categorized into four geometric patterns
according to values of LV mass index and RWT (10): normal
(normal LV mass and normal RWT), concentric remodeling
(normal LV mass and increased RWT), eccentric LVH (in-
creased LV mass and normal RWT), and concentric LVH
(increased LV mass and RWT).
Cardiac catheterization. Patients had both right- and left-
sided cardiac catheterization. Coronary cineangiograms were
obtained in multiple projections. LV angiograms were ob-
tained in the standard 30-degree right anterior oblique projec-
tion, and the ejection fraction was calculated using the Sandler
and Dodge single-plane method (23). Pressure tracings were
recorded on the Hewlett-Packard 4568C system using fluid-
filled catheters. Patients were classified as having CAD if at
least one vessel showed a reduction in diameter of 70% or
more.
Follow-up. An attempt was made to contact all patients
either during an outpatient visit, by telephone or by review of
medical records of clinic attendance. In addition, the database
provided by the National Death Index, which contains a
standard set of identifying data for each death in the United
States, was searched annually, starting from 1982 through
December 31, 1995, for all members of the original cohort
(24). Death certificates were obtained from the State Health
Department, and causes of death were coded in a blinded
fashion. Death from all causes and from cardiac diseases as the
underlying cause were the study end points of this analysis.
Data analysis. All analyses were performed separately
among patients with or without CAD. Mortality rate was
expressed as per 100 patient years. A Cox proportional hazards
model was used to examine the risk of death independently
associated with LV geometric patterns, with normal geometry
as the reference. Classification of geometric patterns was based
on arbitrary cutoff values to define LVH and abnormal RWT.
Hence, we also performed the analyses using LV mass indexed
by body surface area and RWT as continuous variables, and
risks were calculated for each 40g/m2 increment in mass index
and 13% increment in RWT. The units of increment were
approximately equal to 1 SD of the two measures. The two
measures were first entered into the Cox model separately and
then entered simultaneously to examine the independent effect
of each variable. The analyses were adjusted for age, gender,
race and history of hypertension. For patients with angio-
graphically determined CAD, adjustment also included the
number of diseased vessels.
Results
Baseline data. The clinical characteristics of study patients
are presented in Tables 1 and 2. Most of the patients were
hypertensive and African American. As a result of heteroge-
neity and characteristics of this patient series, the mean values
and the associated between-person variation (SD) of the LV
mass and RWT were high. Among 542 patients without
angiographically defined CAD, the distribution of the four
geometric patterns was 25%, 33%, 17%, and 25% for normal,
concentric remodeling, eccentric LVH, and concentric LVH,
respectively. The corresponding distribution was 31%, 19%,
Abbreviations and Acronyms
ASE 5 American Society of Echocardiography
CAD 5 coronary artery disease
LV 5 left ventricular
LVH 5 left ventricular hypertrophy
RWT 5 relative wall thickness
Table 1. Baseline Characteristics of Patients With or Without
Coronary Artery Disease
Variable
Non-CAD
(n 5 542)
CAD
(n 5 446)
Age (yr) 54.0 6 9.6 56.9 6 9.0
Male 36.0% 54.9%
Black 87.1% 76.0%
Hypertension 82.5% 83.0%
Self-reported history of heart attack 30.7% 69.3%
Diabetes 19.7% 32.5%
Body mass index (kg/m2) 29.5 6 6.1 28.3 6 5.3
Catheterization data
Mean aortic pressure (mm Hg) 103 6 16 102 6 17
Mean pulmonary artery pressure (mm Hg) 19 6 8 19 6 8
LVEDP (mm Hg) 11.8 6 5.8 13.3 6 7.4
LVEF (%) 69 6 11 64 6 11
Echocardiographic data
Posterior wall thickness (cm) 1.1 6 0.2 1.2 6 0.2
Interventricular septal thickness (cm) 1.2 6 0.2 1.2 6 0.3
LV end-systolic dimension (cm) 3.0 6 0.8 3.4 6 0.9
LV end-diastolic dimension (cm) 4.7 6 0.7 5.0 6 0.8
Relative wall thickness (%) 50 6 14 48 6 13
LV mass (g) 210 6 74 232 6 86
LV mass index (g/m2) 111 6 39 123 6 43
Data presented are mean value 6 SD or percent of patients. CAD 5
coronary artery disease; LV 5 left ventricular; LVEDP 5 left ventricular
end-diastolic pressure; LVEF 5 left ventricular ejection fraction.
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20% and 30% among 446 patients with CAD. Male and female
composition was not comparable across the four geometric
patterns. Proportionately, more females had either eccentric or
concentric LVH than men. Hence, further analyses were
performed with adjustment for gender. The concentric group
demonstrated the largest increase in the average thickness of
the LV posterior wall, the septum, and in LV mass among all
groups (Table 2) (p , 0.01 after adjustment for gender). No
significant difference in mass or mass index was found between
the normal and the concentric remodeling pattern.
Follow-up data. During a mean follow-up period of 9 years
(range, 4 to 13) 267 patients died, among whom 151 died from
cardiac causes (Table 3). All-cause mortality, ordered from the
lowest to the highest, were normal geometry, concentric re-
model, eccentric, and concentric LVH. For cardiac death, the
progressive increase in mortality was found only from eccentric
and concentric LVH, but not from concentric remodeling.
Multivariate Cox regression analyses showed that the rela-
tive risks of death for concentric remodeling for both disease
categories were not significantly different from 1.0 (Table 4). In
the four comparisons—two end points (all causes and cardiac
deaths) and two classifications of disease—concentric LVH
conferred a significantly increased mortality risk (relative risk
[RR] 2.21 to 2.97). Eccentric hypertrophy was associated with
a moderate increase in risk (RR 1.33 to 2.87).
In contrast to the high correlation of either RWT or LV
mass index to LV end-diastolic dimension (Pearson correlation
coefficient 20.64 and 0.62, respectively), the coefficient be-
tween RWT and LV mass index was only 0.11. Hence, it is
reasonable to evaluate the independent effect of the two
variables in the statistical model. When the two measures were
entered separately as continuous measures in the Cox models,
Table 2. Selected Variables by Left Ventricular Geometry in Patients With or Without Coronary
Artery Disease
Variables Normal
Concentric
Remodeling
Eccentric
LVH
Concentric
LVH
Patients Without Coronary Artery Disease
No. (%) 136 (25) 180 (33) 93 (17) 133 (25)
Age (yr) 51.7 6 9.6 54.3 6 9.9 54.0 6 7.9 56.1 6 9.6
Male (%) 49 43 16 27
Black (%) 77 93 85 91
Posterior wall thickness (cm) 1.0 6 0.1 1.1 6 0.2 1.1 6 0.1 1.4 6 0.2
IVS (cm) 1.0 6 0.1 1.2 6 0.2 1.1 6 0.2 1.4 6 0.3
LV end-systolic dimension (cm) 3.2 6 0.6 2.6 6 0.5 3.8 6 0.9 3.0 6 0.8
LV end-diastolic dimension (cm) 4.9 6 0.4 4.1 6 0.5 5.5 6 0.6 4.7 6 0.7
Relative wall thickness (%) 40 6 4 56 6 11 39 6 4 61 6 16
LV mass (g) 176 6 31 169 6 44 249 6 69 273 6 84
LV mass index (g/m2) 91 6 14 87 6 19 137 6 40 145 6 41
Patients With Coronary Artery Disease
No. (%) 139 (31) 86 (19) 87 (20) 134 (30)
Age (yr) 54.4 6 9.1 56.6 6 9.3 58.0 6 8.5 59.1 6 8.5
Male (%) 73 64 46 36
Posterior wall thickness (cm) 1.0 6 0.1 1.2 6 0.1 1.1 6 0.1 1.4 6 0.2
IVS (cm) 1.0 6 0.1 1.2 6 0.2 1.1 6 0.2 1.4 6 0.2
LV end-systolic dimension (cm) 3.4 6 0.7 2.8 6 0.6 4.2 6 0.9 3.1 6 0.7
LV end-diastolic dimension (cm) 5.1 6 0.5 4.2 6 0.5 5.8 6 0.7 4.8 6 0.6
Relative wall thickness (%) 38 6 6 56 6 10 38 6 5 59 6 11
LV mass (g) 185 6 38 179 6 44 272 6 90 290 6 90
LV mass index (g/m2) 97 6 18 93 6 16 145 6 42 154 6 43
LVH 5 left ventricular hypertrophy; IVS 5 interventricular septal thickness; LV 5 left ventricular.
Table 3. Mortality Rates by Left Ventricular Geometry in Patients
With or Without Coronary Artery Disease
Normal
Concentric
Remodeling
Eccentric
LVH
Concentric
LVH
Patients Without Coronary Artery Disease
No. at baseline 136 180 93 133
No. of deaths
All causes 17 26 21 41
Cardiac related 8 9 13 21
Mortality rate (per
100 patient-yr)
All causes 1.47 1.73 2.76 4.19
Cardiac related 0.69 0.60 1.71 2.15
Patients With Coronary Artery Disease
No. at baseline 139 86 87 134
No. of deaths
All causes 33 24 36 69
Cardiac related 24 12 21 43
Mortality rate (per
100 patient-yr)
All causes 2.68 3.58 5.35 7.63
Cardiac related 1.95 1.79 3.12 4.75
LVH 5 left ventricular hypertrophy.
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increased mass index was associated with increased risk of both
fatal end points among patients with or without CAD (Table
5). RWT was also positively associated with risk of both end
points among patients with CAD. Mass index remained signif-
icantly related to the end points when mass and RWT were
considered simultaneously in the models. However, RWT was
not independently associated with risk.
Additional analyses. To exclude the potential impact of
regional wall motion abnormality on calculation of LV mass,
analyses were repeated excluding 215 patients with prior
self-reported heart attack. Similar results were noted. Addi-
tional analyses were performed using .50% narrowing in any
major coronary artery to define CAD; LV mass indexed for
height, or height2.7; sum of posterior wall thickness and
interventricular septal thickness to calculate RWT; and for
men and women separately. Because there were two patient
groups (CAD and nonCAD), two end points (cardiac and all
causes of death), several different indexes and two genders,
some degree of variation among the different sets of analyses is
expected, especially because the sample sizes were small in
some subgroups. However, the overall results were similar to
the data reported here and there was no apparent gender
differential in the impact of geometric pattern on mortality
based on the limited numbers in this sample.
Discussion
LV geometric patterns. Cardiac adaptation to arterial hy-
pertension may occur in three different LV geometric patterns
(6,10–14). In the presence of normal LV performance, LV
geometry is primarily a consequence of the degree of pressure,
or volume overload, or both (25). It is now evident that these
three geometric adaptations reflect different patterns of hemo-
dynamic overload (10,12,13,15,25,26). LV mass predicts risk of
Table 4. Adjusted Relative Risk and 95% Confidence Interval of Death Associated With Left
Ventricular Geometry in Patients With or Without Coronary Artery Disease
Left Ventricular Geometry
All Causes of Death Cardiac Death
RR 95% CI RR 95% CI
Patients Without Coronary Artery Disease
Normal 1.00 — 1.00 —
Concentric remodeling 0.97 0.53–1.80 0.73 0.28–1.90
Eccentric hypertrophy 2.28* 1.18–4.41 2.87* 1.16–7.07
Concentric hypertrophy 2.60† 1.45–4.64 2.97† 1.29–6.84
Patients With Coronary Artery Disease
Normal 1.00 — 1.00 —
Concentric remodeling 1.48 0.87–2.52 0.98 0.49–1.97
Eccentric hypertrophy 1.94† 1.18–3.18 1.33 0.72–2.45
Concentric hypertrophy 2.92† 1.89–4.51 2.21† 1.31–3.75
*p , 0.05; †p , 0.01. Data presented are adjusted for age, gender, race, hypertension, and ejection fraction and
numbers of diseased vessels for patients with coronary artery disease. RR 5 relative risk; CI 5 confidence interval.
Table 5. Adjusted Relative Risk (95% confidence interval) of Death Associated With Each 40-g/m2
Increment in Left Ventricular Mass Index and Each 13% Increment in Relative Wall Thickness
Cause of Death
Non-CAD CAD
LV Mass RWT LV Mass RWT
LV Mass Index and RWT in the Separate Models (95% CI)
All causes 1.54* 1.15 1.37* 1.22†
(1.33–1.78) (0.96–1.38) (1.20–1.57) (1.06–1.41)
Cardiac related 1.79* 1.02 1.36* 1.22†
(1.49–2.15) (0.77–1.35) 1.14–1.61) (1.02–1.46)
LV Mass Index and RWT in the Same Model (95% CI)
All causes 1.55* 1.14 1.33* 1.13
(1.34–1.79) (0.96–1.36) (1.15–1.53) (0.97–1.32)
Cardiac related 1.79* 1.01 1.31* 1.13
(1.49–2.15) (0.77–1.33) (1.09–1.57) (0.93–1.37)
*p , 0.01; †p , 0.05. Data presented are adjusted for age, gender, race, hypertension, and ejection fraction and
numbers of diseased vessels for patients with coronary artery disease. CAD 5 coronary artery disease; LV 5 left
ventricular; RWT 5 relative wall thickness; CI 5 confidence interval.
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cardiovascular events independently of blood pressure, other
risk factors or presence of CAD (1–7). Whether further
classification of LV geometric patterns adds to ventricular
mass for stratification of risk is unresolved (6,15–17).
Previous studies. Koren et al. (6) first reported that clas-
sification by LV geometry enhanced prediction of prognosis in
patients with uncomplicated essential hypertension. The 10-
year mortality rate was 1%, 6%, 10% and 24% for patients
with normal, concentric remodeling, eccentric and concentric
LVH, respectively. The limited sample size, however, did not
allow for a multivariate analysis. The study by Verdecchia et al.
(15) confirmed the adverse prognostic significance of concen-
tric remodeling in 694 hypertensive patients without LVH. The
incidence of morbid events was 2.39 in 100 patient-years in
those with concentric remodeling and 1.12 in those with
normal LV geometry, yielding a multivariate-adjusted RR of
2.56 (95% confidence interval 1.20 to 5.45). The geometry
paradigm has been used to argue that lumping hypertensive
patients together without consideration of their LV patterns
may account for discrepancies in the pharmacological trials
(27,28). Another recent study, though, by Verdecchia et al.
(17) on hypertensive patients with LVH showed that LV mass,
but not its geometric pattern, provided prognostic value. The
Framingham Heart Study, from a general Caucasian popula-
tion sample, also did not support the independent role of
geometry (16). The association between type of geometry and
prognosis was largely attenuated by adjustment for LV mass.
Our study from a predominantly African-American patient
series agreed with these findings.
The current study. In our patient series, normal LV geo-
metric pattern was present in only 31% and 25% of patients,
with and without CAD, respectively. The prevalence of abnor-
mal LV geometric patterns in our study contrasts with the
observations by others (6,16). Koren et al. (6) reported that
more than half of uncomplicated hypertensives, with a younger
average age than our series, had a normal LV geometric
pattern. Three-fourths of the healthy population in the Fra-
mingham Study had normal geometry (16). The magnitude of
LV mass is much higher across the board in all geometric
patterns in our patients as compared to the two studies
mentioned above (6,16), consistent with previous reports. Our
data, though, also showed that there was a progressive increase
in LV mass from the normal group to eccentric and then to
concentric LVH group. However, we found no significant
difference in LV mass among those with concentric remodeling
as compared with the normal group. There have been diverse
findings among studies, with one common outcome—
morbidity or mortality risk parallels the increase in LV mass.
At the same time, the impact of RWT independent of LV mass
was not clearly demonstrated.
One of the major limitations for most investigations of the
LV geometry patterns is the limited sample size (6,15,17). The
report from Koren et al. (6) included 19 deaths and 40
cardiovascular events, and the number of events in the studies
by Verdecchia et al. was only 29 in one study (15) and 24 in
another (17). In the current study, despite the relatively large
size of the cohort and the high mortality rate, after dividing
into four geometric patterns and separating the patients on the
basis of coronary disease, the number of fatal events in each
group was small. Therefore, we have analyzed mass index and
RWT as continuous measures and considered them in the
same statistical model. Although there were some concerns
about the biological implication of holding ventricular mass
constant while adjusting for RWT (29), given the weak corre-
lation between the two variables, this approach is more appro-
priate and avoids further reducing the sample size by classifi-
cation of LVH and abnormal RWT using arbitrary cut points.
These data provide more secure results. RWT is the ratio of
the two components: wall thickness and ventricular chamber
size, and the latter is highly correlated to the calculated LV
mass. The results of current analyses indicate that if the total
LV mass is not increased, increasing LV wall thickness with
decreasing chamber size does not adversely affect mortality.
Limitations. There are several limitations of this study.
The patients were part of a hospital-based registry, and many
factors could influence their selection and outcome. All pa-
tients underwent cardiac catheterization for suspected CAD.
The mortality rate of this patient series was much higher than
that in the general population (16) or samples of uncompli-
cated hypertensives (6,15–17). Thus, our patients may not
necessarily represent the population at large. Causes of death
were defined based on the death certificates, which may have
resulted in some classification errors, especially in patients who
died outside the hospital. This study examined only mortality
as an outcome. The possibility that increases in RWT may
confer an increase in morbidity, including congestive heart
failure, could not be assessed. Finally, the sample size of this
study did not permit further detailed analysis by gender.
Conclusions. The patients with both LVH and abnormal
RWT—concentric LVH—represent an extreme group with
the greatest risk of mortality. Concentric remodeling was not
associated with increased risk of death, because the predictive
value of RWT was not as strong as for LV mass.
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